Nasdaq · Healthcare
BICYCLE THERAPEUTICS PLC (BCYC)
As-reported financials and recent SEC filings for BICYCLE THERAPEUTICS PLC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$72.6M
Net income
$-219.0M
Net margin
—
Diluted EPS
$-3.16
ROE
-35.9%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $72.6M | $35.3M | $27.0M | $14.5M | $11.7M |
| Gross profit | — | — | — | — | — |
| Operating income | $-247.1M | $-209.9M | $-189.9M | $-116.7M | $-65.6M |
| Net income | $-219.0M | $-169.0M | $-180.7M | $-112.7M | $-66.8M |
| Diluted EPS | $-3.16 | $-2.90 | $-5.08 | $-3.80 | $-2.67 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-07-02
View on EDGAR →8-K2026-06-18
View on EDGAR →8-K2026-05-21
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →SCHEDULE 13G2026-05-15
View on EDGAR →SCHEDULE 13G/A2026-05-04
View on EDGAR →10-Q2026-04-30
View on EDGAR →8-K2026-04-30
View on EDGAR →Largest Healthcare peers
Go deeper on BCYC
Search BICYCLE THERAPEUTICS PLC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.